Judge Approves $7.25 Billion Roundup Settlement for Non-Hodgkin Lymphoma Claims

Roundup settlement approval: A Missouri judge has approved a $7.25 billion settlement from lawsuits alleging Bayer's Roundup weedkiller causes cancer. The payments cover people already sick with non-Hodgkin lymphoma and those who become ill in future, with individual awards ranging from $10,000 to $165,000.

Roundup settlement approval, Digimart Global (Missouri, United States): A Missouri judge on Friday approved a $7.25 billion (£5.5 billion) settlement stemming from lawsuits alleging that Bayer’s weedkiller Roundup causes cancer. Judge Timothy Boyer said the settlement was “fair, reasonable, and adequate”.

Bayer, the German biotech company, had proposed paying the $7.25 billion to definitively resolve a legal battle in the United States. The nationwide settlement will be paid to Roundup users who are already sick with non-Hodgkin lymphoma and to those who fall ill in the future.

Payment terms and scale

Settlement amounts for participants range from $10,000 to $165,000, depending on how often they used the product, when they were diagnosed and how severe their illness was. Bayer will make annual payments into a fund for up to 21 years, providing as much as $7.25 billion.

The company had already paid roughly $10 billion to resolve earlier Roundup litigation.

Some attorneys objected that the settlement funds were not enough, but the judge said he did not want to delay payouts to sick victims. Bayer denies that its Roundup product causes cancer.

Background to the litigation

The approval follows a June Supreme Court ruling in Bayer’s favour. The court overturned a $1.25 million award to a Missouri man who said Roundup and its ingredient glyphosate caused his non-Hodgkin lymphoma.

The court ruled 7-2 that Bayer cannot be sued in state courts because federal regulations do not mandate a cancer warning label.

The company has faced thousands of claims in US state and federal courts from people alleging they developed cancer after using the product. Roundup was developed by Monsanto in the 1970s.

In 2015, the International Agency for Research on Cancer, a unit of the World Health Organization, identified its active ingredient, glyphosate, as a probable human carcinogen. Bayer and some other regulators, including the US Environmental Protection Agency, have disputed those findings.

The report notes that juries in several states have awarded billions of dollars to herbicide users, forcing the company through years of costly litigation in the US.

Sophia Bennett

Sophia Bennett covers artificial intelligence, emerging technologies, cybersecurity, and major developments in the U.S. technology industry. Her stories explore the impact of innovation on businesses and daily life.

Leave a Reply

Your email address will not be published. Required fields are marked *

Sports

Explore Digimart Global